 |
 |
 |
|
|
||||
|
|||||
|
|||||
 |
 |
 |
Disclaimer: This is not for further dissemination.
This is an international website for the ATTRACT program. The information on this site is not country-specific and may contain ATTRACT program information that is different from where you practice. Please contact your local Novartis representative for the latest ATTRACT information specific to your country. ASA404 is investigational. Efficacy and safety have not been established. There is no guarantee that this compound will become commercially available. Home | What is ASA404? | ATTRACT - 1 | ATTRACT - 2 | Disease Information | Tell your Colleagues ATTRACT – 1 | Tell your Colleagues ATTRACT – 2 About Novartis Oncology | Additional Information on Clinical Trials Contact Information | Contact | Site Map | Privacy. Use of this website is subject to our Terms of Use © 2010 Novartis AG. |
Home